Ibrahim, A. R., Clark, R. E., Holyoake, T. L., Byrne, J., Shepherd, P., Apperley, J. F., Milojkovic, D., Szydlo, R., Goldman, J. and Marin, D. (2011) “Second-generation tyrosine kinase inhibitors improve the survival of patients with chronic myeloid leukemia in whom imatinib therapy has failed”, Haematologica. Pavia, Italy, 96(12), pp. 1779-1782. doi: 10.3324/haematol.2011.049759.